Clinical Trial Update: A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 study of LP-300 with carboplatin and pemetrexed in never-smokers with advanced lung adenocarcinoma; trial currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma
• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• LP-300
• Pemetrexed (pemetrexed)

Snippet

Sponsor: Lantern Pharma Inc. | Conditions: Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: RECRUITING